Dunhill Financial »

Fate Therapeutics shares owned by Dunhill Financial

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Dunhill Financial from 13F filings

Historical chart of Dunhill Financial investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Dunhill Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Dunhill Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $23k 3.2k 7.34
2023-12-31 $12k 3.2k 3.74

More positions owned by Dunhill Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Kld400 Soc (DSI)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
First Tr Exchange-traded Buywrit Incm Etf (FTHI)
Pimco Etf Tr Active Bd Etf (BOND)
Ishares Tr Esg Aw Msci Eafe (ESGD)
Vanguard Index Fds Small Cp Etf (VB)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Old Republic International Corporation (ORI)
First Tr Exchange Traded Nasdaq Cyb Etf (CIBR)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 3000 Etf (IWV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)

View all positions for Dunhill Financial

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
BlackRock
Boxer Capital
Bellevue Group
Johnson & Johnson
Citadel Advisors
Morgan Stanley
D. E. Shaw & Co
Suvretta Capital Management
Assenagon Asset Management
Holocene Advisors
Deerfield Management Company
Adage Capital Partners GP
Goldman Sachs Group

View all funds holding Fate Therapeutics